228 related articles for article (PubMed ID: 31897803)
1. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
3. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
So K; Smith RE; Davis SR
ANZ J Surg; 2016 Sep; 86(9):696-700. PubMed ID: 26573999
[TBL] [Abstract][Full Text] [Related]
5. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
Schwartz DL; Lobo MJ; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Evans DB; Clayman G; Sherman SI; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1083-91. PubMed ID: 19095376
[TBL] [Abstract][Full Text] [Related]
6. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
7. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
10. External beam radiotherapy for differentiated thyroid cancer.
Meadows KM; Amdur RJ; Morris CG; Villaret DB; Mazzaferri EL; Mendenhall WM
Am J Otolaryngol; 2006; 27(1):24-8. PubMed ID: 16360819
[TBL] [Abstract][Full Text] [Related]
11. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea.
Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):474-80. PubMed ID: 16542796
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Thyrotropin Alfa Versus Levothyroxine Withdrawal-Aided Radioiodine Therapy for Distant Metastasis of Papillary Thyroid Cancer.
Simões-Pereira J; Ferreira TC; Limbert E; Cavaco BM; Leite V
Thyroid; 2021 Oct; 31(10):1514-1522. PubMed ID: 34155923
[No Abstract] [Full Text] [Related]
13. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.
Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I
Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700
[TBL] [Abstract][Full Text] [Related]
14. Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies.
Hartung-Knemeyer V; Nagarajah J; Jentzen W; Ruhlmann M; Freudenberg LS; Stahl AR; Bockisch A; Rosenbaum-Krumme SJ
Ann Nucl Med; 2012 Nov; 26(9):723-9. PubMed ID: 22802008
[TBL] [Abstract][Full Text] [Related]
15. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
[TBL] [Abstract][Full Text] [Related]
16. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
Lin JD; Tsang NM; Huang MJ; Weng HF
Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
[TBL] [Abstract][Full Text] [Related]
17. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas.
Petersen IA; Haddock MG; Donohue JH; Nagorney DM; Grill JP; Sargent DJ; Gunderson LL
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):469-75. PubMed ID: 11872294
[TBL] [Abstract][Full Text] [Related]
18. Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience.
Besic N; Dremelj M; Pilko G
Radiol Oncol; 2018 Sep; 52(4):453-460. PubMed ID: 30244234
[TBL] [Abstract][Full Text] [Related]
19. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer.
Kim TH; Chung KW; Lee YJ; Park CS; Lee EK; Kim TS; Kim SK; Jung YS; Ryu JS; Kim SS; Cho KH; Shin KH
Radiat Oncol; 2010 Aug; 5():69. PubMed ID: 20687967
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
